Comments
Loading...
Repligen (RGEN) Forecast
NewsEarningsRepligen (RGEN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Repligen Stock Price, Quotes and Forecasts | NASDAQ:RGEN | Benzinga
Explore Repligen stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RGEN.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Repligen (RGEN) stock?
You can purchase shares of Repligen (NASDAQ:RGEN) through any online brokerage.
Who are Repligen (RGEN) competitors?
Other companies in Repligen’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), BioLife Solutions (NASDAQ:BLFS) and Waters (NYSE:WAT).
What is the forecast, or price target, for Repligen (RGEN) stock?
Repligen has a consensus price target of $186.57.
What is the current price for Repligen (RGEN)?
The stock price for Repligen (NASDAQ: RGEN) is $131.1525 last updated April 16, 2025 at 11:13 AM EDT.
Does Repligen (RGEN) pay a dividend?
There are no upcoming dividends for Repligen.
When is Repligen (NASDAQ:RGEN) reporting earnings?
Repligen’s Q1 earnings are confirmed for Tuesday, April 29, 2025.
Is Repligen (RGEN) going to split?
There is no upcoming split for Repligen.
What sector and industry does Repligen (RGEN) operate in?
Repligen is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.